Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease

Detalhes bibliográficos
Autor(a) principal: Simão, André
Data de Publicação: 2023
Outros Autores: Palma, Carolina, Izquierdo-Sanchez, Laura, Putignano, Antonella, Carvalho-Gomes, Angela, Posch, Andreas, Zanaga, Paola, Girleanu, Irina, Henrique, Mariana, Araújo, Carlos, Degre, Delphine, Gustot, Thierry, Sahuco, Iván, Spagnolo, Elia, Carvalhana, Sofia, Moura, Miguel, Fernandes, Diogo AE., Banales, Jesus M., Romero-Gomez, Manuel, Trifan, Anca, Russo, Francesco Paolo, Stauber, Rudolf, Berenguer, Marina, Moreno, Christophe, Gonçalves, João manuel braz, Cortez-Pinto, Helena, Castro, Rui E.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/57127
Resumo: © 2023 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
id RCAP_73bff137be94254ad25be8534815571f
oai_identifier_str oai:repositorio.ul.pt:10451/57127
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver diseaseCOVID-19 vaccineChronic liver diseaseCirrhosisHumoral immunitySARS-CoV-2© 2023 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Background & aims: The response of patients with chronic liver disease (CLD) to COVID-19 vaccines remains unclear. Our aim was to assess the humoral immune response and efficacy of two-dose COVID-19 vaccines among patients with CLD of different aetiologies and disease stages. Methods: A total of 357 patients were recruited in clinical centres from six European countries, and 132 healthy volunteers served as controls. Serum IgG (nM), IgM (nM), and neutralising antibodies (%) against the Wuhan-Hu-1, B.1.617, and B.1.1.529 SARS-CoV-2 spike proteins were determined before vaccination (T0) and 14 days (T2) and 6 months (T3) after the second-dose vaccination. Patients fulfilling inclusion criteria at T2 (n = 212) were stratified into 'low' or 'high' responders according to IgG levels. Infection rates and severity were collected throughout the study. Results: Wuhan-Hu-1 IgG, IgM, and neutralisation levels significantly increased from T0 to T2 in patients vaccinated with BNT162b2 (70.3%), mRNA-1273 (18.9%), or ChAdOx1 (10.8%). In multivariate analysis, age, cirrhosis, and type of vaccine (ChAdOx1 > BNT162b2 > mRNA-1273) predicted 'low' humoral response, whereas viral hepatitis and antiviral therapy predicted 'high' humoral response. Compared with Wuhan-Hu-1, B.1.617 and, further, B.1.1.529 IgG levels were significantly lower at both T2 and T3. Compared with healthy individuals, patients with CLD presented with lower B.1.1.529 IgGs at T2 with no additional key differences. No major clinical or immune IgG parameters associated with SARS-CoV-2 infection rates or vaccine efficacy. Conclusions: Patients with CLD and cirrhosis exhibit lower immune responses to COVID-19 vaccination, irrespective of disease aetiology. The type of vaccine leads to different antibody responses that appear not to associate with distinct efficacy, although this needs validation in larger cohorts with a more balanced representation of all vaccines. Impact and implications: In patients with CLD vaccinated with two-dose vaccines, age, cirrhosis, and type of vaccine (Vaxzevria > Pfizer BioNTech > Moderna) predict a 'lower' humoral response, whereas viral hepatitis aetiology and prior antiviral therapy predict a 'higher' humoral response. This differential response appears not to associate with SARS-CoV-2 infection incidence or vaccine efficacy. However, compared with Wuhan-Hu-1, humoral immunity was lower for the Delta and Omicron variants, and all decreased after 6 months. As such, patients with CLD, particularly those older and with cirrhosis, should be prioritised for receiving booster doses and/or recently approved adapted vaccines.Partial funds were provided through Fundação para a Ciência e a Tecnologia (grants PTDC/MED-PAT/31882/2017 and EXPL/MED-OUT/1317/2021) and through La Caixa Scientific Foundation (grant HR17-00601).ElsevierRepositório da Universidade de LisboaSimão, AndréPalma, CarolinaIzquierdo-Sanchez, LauraPutignano, AntonellaCarvalho-Gomes, AngelaPosch, AndreasZanaga, PaolaGirleanu, IrinaHenrique, MarianaAraújo, CarlosDegre, DelphineGustot, ThierrySahuco, IvánSpagnolo, EliaCarvalhana, SofiaMoura, MiguelFernandes, Diogo AE.Banales, Jesus M.Romero-Gomez, ManuelTrifan, AncaRusso, Francesco PaoloStauber, RudolfBerenguer, MarinaMoreno, ChristopheGonçalves, João manuel brazCortez-Pinto, HelenaCastro, Rui E.2023-04-13T16:53:18Z20232023-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/57127engJHEP Rep. 2023 May;5(5):10069710.1016/j.jhepr.2023.1006972589-5559info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T17:05:10Zoai:repositorio.ul.pt:10451/57127Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:07:33.297874Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease
title Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease
spellingShingle Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease
Simão, André
COVID-19 vaccine
Chronic liver disease
Cirrhosis
Humoral immunity
SARS-CoV-2
title_short Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease
title_full Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease
title_fullStr Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease
title_full_unstemmed Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease
title_sort Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease
author Simão, André
author_facet Simão, André
Palma, Carolina
Izquierdo-Sanchez, Laura
Putignano, Antonella
Carvalho-Gomes, Angela
Posch, Andreas
Zanaga, Paola
Girleanu, Irina
Henrique, Mariana
Araújo, Carlos
Degre, Delphine
Gustot, Thierry
Sahuco, Iván
Spagnolo, Elia
Carvalhana, Sofia
Moura, Miguel
Fernandes, Diogo AE.
Banales, Jesus M.
Romero-Gomez, Manuel
Trifan, Anca
Russo, Francesco Paolo
Stauber, Rudolf
Berenguer, Marina
Moreno, Christophe
Gonçalves, João manuel braz
Cortez-Pinto, Helena
Castro, Rui E.
author_role author
author2 Palma, Carolina
Izquierdo-Sanchez, Laura
Putignano, Antonella
Carvalho-Gomes, Angela
Posch, Andreas
Zanaga, Paola
Girleanu, Irina
Henrique, Mariana
Araújo, Carlos
Degre, Delphine
Gustot, Thierry
Sahuco, Iván
Spagnolo, Elia
Carvalhana, Sofia
Moura, Miguel
Fernandes, Diogo AE.
Banales, Jesus M.
Romero-Gomez, Manuel
Trifan, Anca
Russo, Francesco Paolo
Stauber, Rudolf
Berenguer, Marina
Moreno, Christophe
Gonçalves, João manuel braz
Cortez-Pinto, Helena
Castro, Rui E.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Simão, André
Palma, Carolina
Izquierdo-Sanchez, Laura
Putignano, Antonella
Carvalho-Gomes, Angela
Posch, Andreas
Zanaga, Paola
Girleanu, Irina
Henrique, Mariana
Araújo, Carlos
Degre, Delphine
Gustot, Thierry
Sahuco, Iván
Spagnolo, Elia
Carvalhana, Sofia
Moura, Miguel
Fernandes, Diogo AE.
Banales, Jesus M.
Romero-Gomez, Manuel
Trifan, Anca
Russo, Francesco Paolo
Stauber, Rudolf
Berenguer, Marina
Moreno, Christophe
Gonçalves, João manuel braz
Cortez-Pinto, Helena
Castro, Rui E.
dc.subject.por.fl_str_mv COVID-19 vaccine
Chronic liver disease
Cirrhosis
Humoral immunity
SARS-CoV-2
topic COVID-19 vaccine
Chronic liver disease
Cirrhosis
Humoral immunity
SARS-CoV-2
description © 2023 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
publishDate 2023
dc.date.none.fl_str_mv 2023-04-13T16:53:18Z
2023
2023-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/57127
url http://hdl.handle.net/10451/57127
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv JHEP Rep. 2023 May;5(5):100697
10.1016/j.jhepr.2023.100697
2589-5559
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134629129617408